EUnetHTA Magazine – Autumn 2019 – Now Available

We are pleased to publish the Autumn 2019 issue of EUnetHTA Magazine.  Intended for improved accessibility on whichever device you use, this issue includes various contributions from the EUnetHTA member network, while updating information on EUnetHTA products and the state of HTA in Europe. As always, we welcome your feedback so we can continue to […]

Minutes from the EMA-EUnetHTA July 2019 Meeting now available

The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by the EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 4th July, 2019, are now available for access. Topics discussed included recent experiences with exchanges on medicinal products, practices and experiences related to patient involvement, and compliance with post marketing activities. The minutes can be […]

REQueST Tool and its vision paper are now available for access.

The Registry Evaluation and Quality Standards Tool (REQueST) aims to support HTA organisations and other actors in guiding and evaluating registries for effective usage in HTA. Following public consultation, a finalised version of the tool, together with its vision paper, a document that explores the options for the long-term delivery, use and sustainability of REQueST […]

Minutes from the EMA-EUnetHTA December 2018 Meeting now available

The minutes from the EMA-EUnetHTA Meeting, hosted by the European Medicines Agency on 7th December 2018, are now available for access. This was the 16th meeting between the EMA and EUnetHTA, with representatives from both organisations in attendance as well as attendance from the European Commission. In addition, payer organisations attended as observers. Agenda topics […]

Open Call for Patient Input for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over.

Patient group input requested for a new Joint Assessment on a medicinal product for the prevention of vaso-occlusive crises in sickle cell disease (SCD) patients aged 16 years and over. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique knowledge […]

OTCA19 – ”Screening for osteoporosis in the general population” final assessment and related documentation is now available

EUnetHTA is pleased to announce that the final project plan, final assessment, comments from the external experts and authors’ answers, together with the final abstract and plain language summary for OTCA19 “Screening for osteoporosis in the general population” are now available for access. There were no manufacturers involved in this project. Screening for osteoporosis aims […]

The public consultation of the draft methodological guideline “Practical considerations when critically assessing economic evaluations” is OPEN (deadline Oct. 11, 2019)

We are pleased to announce that, as of today, the draft methodological guideline “Practical considerations when critically assessing economic evaluations”, produced within WP6 B2, has entered the public consultation phase. This consultation will be open until 11th October, 2019.   Objective of the methodological guideline EUnetHTA´s methodological guidelines are targeted to the needs of health […]